We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Moore Kuehn, PLLC Encourages Investors of KEM, ARQL, THOR, and LOGM to Contact the Firm PR Newswire NEW YORK, Jan. 6, 2020 NEW YORK, Jan. 6, 2020 /PRNewswire/ --Β Moore Kuehn, PLLC, a securities...
SHAREHOLDER ALERT: WeissLaw LLP Investigates ArQule, Inc. PR Newswire NEW YORK, Dec. 12, 2019 NEW YORK, Dec. 12, 2019 /PRNewswire/ --Β WeissLaw LLPΒ is investigating possible breaches of fiduciary...
By Jared S. Hopkins and Denise Roland This article is being republished as part of our daily reproduction of WSJ.com articles that also appeared in the U.S. print edition of The Wall Street...
By Jared S. Hopkins and Denise Roland Two of the world's biggest drugmakers struck multibillion-dollar deals on Monday aimed at bolstering their lineups in the fiercely competitive...
By Jared S. Hopkins and Denise Roland Two of the world's biggest drugmakers struck multibillion-dollar deals on Monday aimed at bolstering their lineups in the fiercely competitive...
By Paul J. Davies and Paul Vigna U.S. stocks slipped Monday after fresh economic data showed a sharp decline in Chinese exports to the U.S., highlighting the impact of the trade war between the...
By Jared S. Hopkins and Denise Roland Two of the world's biggest drugmakers struck multibillion-dollar deals on Monday aimed at bolstering their lineups in the fiercely competitive...
By Dave Sebastian and Colin Kellaher Merck & Co. said it is buying ArQule Inc. for about $2.7 billion, adding to its portfolio of cancer treatments beyond the company's top-selling...
- ARQ 531 demonstrates substantial anti-tumor activity and manageable safety profile - Eight of nine evaluable CLL patients initially dosed at β₯65 mg experienced a Partial Response (PR) - Five of...
(ARQL) Alert: Johnson Fistel Investigates Proposed Sale of ArQule, Inc.; Is $20 a Fair Price? PR Newswire SAN DIEGO, Dec. 9, 2019 SAN DIEGO, Dec. 9, 2019 /PRNewswire/ -- Shareholder rights law...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
12 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
26 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
52 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
156 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
260 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions